AstraZeneca’s Imfinzi fails to meet main goals in head and neck cancer study

Read more

Lupin’s Pithampur Unit-3 receives EIR from US FDA

Read more

Amlodipine/Valsartan recalled for possible cancer risk

Read more

Alembic Pharmaceuticals gets US FDA nod for ophthalmic solution

Read more

AstraZeneca Pharma inks distribution pact with Abbott for diabetes drug

Read more

Eisai, UCL commence phase I clinical studies for anti-tau monoclonal antibody

Read more

Polish Investment & Trade Agency to be part of CPhI & P-MEC India 2018

Read more

Datwyler starts commercial production at First Line in Pune, India

Read more

US FDA completes inspection of Lupin’s Mandideep location

Read more

Goa Pharma Summit Special – November 2018

Read more